ID   COMT_HUMAN              Reviewed;         271 AA.
AC   P21964; A8MPV9; Q6IB07; Q6ICE6; Q9BWC7;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 2.
DT   10-MAY-2017, entry version 197.
DE   RecName: Full=Catechol O-methyltransferase;
DE            EC=2.1.1.6;
GN   Name=COMT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=1707278; DOI=10.1089/dna.1991.10.181;
RA   Lundstroem K., Salminen M., Jalanko A., Savolainen R., Ulmanen I.;
RT   "Cloning and characterization of human placental catechol-O-
RT   methyltransferase cDNA.";
RL   DNA Cell Biol. 10:181-189(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-34.
RX   PubMed=1847521; DOI=10.1073/pnas.88.4.1416;
RA   Bertocci B., Miggiano V., da Prada M., Dembic Z., Lahm H.-W.,
RA   Malherbe P.;
RT   "Human catechol-O-methyltransferase: cloning and expression of the
RT   membrane-associated form.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:1416-1420(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8055944; DOI=10.1111/j.1432-1033.1994.tb19083.x;
RA   Tenhunen J., Salminen M., Lundstroem K., Kiviluoto T., Savolainen R.,
RA   Ulmanen I.;
RT   "Genomic organization of the human catechol O-methyltransferase gene
RT   and its expression from two distinct promoters.";
RL   Eur. J. Biochem. 223:1049-1059(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Li J.Y., Wang H.Y., Liu J., Liu F.J.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT MET-158.
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-72 AND MET-158.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT MET-158.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 52-61, AND MASS SPECTROMETRY.
RX   PubMed=8020475; DOI=10.1111/j.1432-1033.1994.tb18876.x;
RA   Vilbois F., Caspers P., da Prada M., Lang G., Karrer C., Lahm H.W.,
RA   Cesura A.M.;
RT   "Mass spectrometric analysis of human soluble catechol O-
RT   methyltransferase expressed in Escherichia coli. Identification of a
RT   product of ribosomal frameshifting and of reactive cysteines involved
RT   in S-adenosyl-L-methionine binding.";
RL   Eur. J. Biochem. 222:377-386(1994).
RN   [13]
RP   PROTEIN SEQUENCE OF 59-271.
RC   TISSUE=Placenta;
RX   PubMed=1993083; DOI=10.1016/0006-291X(91)91517-G;
RA   Tilgmann C., Kalkkinen N.;
RT   "Purification and partial sequence analysis of the soluble catechol-O-
RT   methyltransferase from human placenta: comparison to the rat liver
RT   enzyme.";
RL   Biochem. Biophys. Res. Commun. 174:995-1002(1991).
RN   [14]
RP   CHARACTERIZATION OF THE TWO FORMS.
RX   PubMed=1765063; DOI=10.1111/j.1432-1033.1991.tb16464.x;
RA   Ulmanen I., Lundstroem K.;
RT   "Cell-free synthesis of rat and human catechol O-methyltransferase.
RT   Insertion of the membrane-bound form into microsomal membranes in
RT   vitro.";
RL   Eur. J. Biochem. 202:1013-1020(1991).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=21846718; DOI=10.1074/jbc.M111.262790;
RA   Chen J., Song J., Yuan P., Tian Q., Ji Y., Ren-Patterson R., Liu G.,
RA   Sei Y., Weinberger D.R.;
RT   "Orientation and cellular distribution of membrane-bound catechol-O-
RT   methyltransferase in cortical neurons: implications for drug
RT   development.";
RL   J. Biol. Chem. 286:34752-34760(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 52-264 OF MUTANTS VAL-108 AND
RP   MET-108 IN COMPLEX WITH SUBSTRATE ANALOG 3,5-DINITROCATECHOL;
RP   MAGNESIUM AND S-ADENOSYL-L-METHIONINE.
RX   PubMed=18486144; DOI=10.1016/j.jmb.2008.04.040;
RA   Rutherford K., Le Trong I., Stenkamp R.E., Parson W.W.;
RT   "Crystal structures of human 108V and 108M catechol O-
RT   methyltransferase.";
RL   J. Mol. Biol. 380:120-130(2008).
RN   [20]
RP   VARIANT COMT*2 MET-158.
RX   PubMed=8807664;
RA   Lachman H.M., Papolos D.F., Saito T., Yu Y.-M., Szumlanski C.L.,
RA   Weinshilboum R.M.;
RT   "Human catechol-O-methyltransferase pharmacogenetics: description of a
RT   functional polymorphism and its potential application to
RT   neuropsychiatric disorders.";
RL   Pharmacogenetics 6:243-250(1996).
RN   [21]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO ALCOHOLISM.
RX   PubMed=10395222; DOI=10.1038/sj.mp.4000509;
RA   Tiihonen J., Hallikainen T., Lachman H., Saito T., Volavka J.,
RA   Kauhanen J., Salonen J.T., Ryynaenen O.-P., Koulu M., Karvonen M.K.,
RA   Pohjalainen T., Syvaelahti E., Hietala J.;
RT   "Association between the functional variant of the catechol-O-
RT   methyltransferase (COMT) gene and type 1 alcoholism.";
RL   Mol. Psychiatry 4:286-289(1999).
RN   [22]
RP   VARIANTS SER-34 AND SER-72.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [23]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [24]
RP   CHARACTERIZATION OF VARIANT SER-72, AND POSSIBLE INVOLVEMENT IN
RP   SCHIZOPHRENIA.
RX   PubMed=15645182; DOI=10.1007/s00439-004-1239-y;
RA   Lee S.-G., Joo Y., Kim B., Chung S., Kim H.-L., Lee I., Choi B.,
RA   Kim C., Song K.;
RT   "Association of Ala72Ser polymorphism with COMT enzyme activity and
RT   the risk of schizophrenia in Koreans.";
RL   Hum. Genet. 116:319-328(2005).
RN   [25]
RP   CHARACTERIZATION OF VARIANT COMT*2 MET-158.
RX   PubMed=18474266; DOI=10.1016/j.bbapap.2008.04.006;
RA   Rutherford K., Alphandery E., McMillan A., Daggett V., Parson W.W.;
RT   "The V108M mutation decreases the structural stability of catechol O-
RT   methyltransferase.";
RL   Biochim. Biophys. Acta 1784:1098-1105(2008).
RN   [26]
RP   VARIANT COMT*2 MET-158.
RX   PubMed=18442637; DOI=10.1016/j.metabol.2008.01.012;
RA   Annerbrink K., Westberg L., Nilsson S., Rosmond R., Holm G.,
RA   Eriksson E.;
RT   "Catechol O-methyltransferase val158-met polymorphism is associated
RT   with abdominal obesity and blood pressure in men.";
RL   Metabolism 57:708-711(2008).
CC   -!- FUNCTION: Catalyzes the O-methylation, and thereby the
CC       inactivation, of catecholamine neurotransmitters and catechol
CC       hormones. Also shortens the biological half-lives of certain
CC       neuroactive drugs, like L-DOPA, alpha-methyl DOPA and
CC       isoproterenol.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + a catechol = S-
CC       adenosyl-L-homocysteine + a guaiacol.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 1 Mg(2+) ion per subunit.;
CC   -!- INTERACTION:
CC       P30260:CDC27; NbExp=3; IntAct=EBI-10200977, EBI-994813;
CC       Q15323:KRT31; NbExp=3; IntAct=EBI-10200977, EBI-948001;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-10200977, EBI-10171697;
CC       P26371:KRTAP5-9; NbExp=3; IntAct=EBI-10200977, EBI-3958099;
CC       Q15645:TRIP13; NbExp=3; IntAct=EBI-10200977, EBI-358993;
CC   -!- SUBCELLULAR LOCATION: Isoform Soluble: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform Membrane-bound: Cell membrane;
CC       Single-pass type II membrane protein; Extracellular side
CC       {ECO:0000269|PubMed:21846718}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Membrane-bound; Synonyms=MB-COMT;
CC         IsoId=P21964-1; Sequence=Displayed;
CC       Name=Soluble; Synonyms=S-COMT;
CC         IsoId=P21964-2; Sequence=VSP_018778;
CC   -!- TISSUE SPECIFICITY: Brain, liver, placenta, lymphocytes and
CC       erythrocytes.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- MASS SPECTROMETRY: Mass=24352; Mass_error=2; Method=Electrospray;
CC       Range=52-271; Evidence={ECO:0000269|PubMed:8020475};
CC   -!- POLYMORPHISM: Two alleles, COMT*1 or COMT*H with Val-158 and
CC       COMT*2 or COMT*L with Met-158 are responsible for a three to four-
CC       fold difference in enzymatic activity.
CC       {ECO:0000269|PubMed:18442637, ECO:0000269|PubMed:18474266,
CC       ECO:0000269|PubMed:8807664}.
CC   -!- POLYMORPHISM: Low enzyme activity alleles are associated with
CC       genetic susceptibility to alcoholism [MIM:103780].
CC       {ECO:0000269|PubMed:10395222}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding
CC       methyltransferase superfamily. Cation-dependent O-
CC       methyltransferase family. {ECO:0000255|PROSITE-ProRule:PRU01019}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH00419.2; Type=Erroneous termination; Positions=85; Note=Translated as Gln.; Evidence={ECO:0000305};
CC       Sequence=AAH05867.1; Type=Erroneous termination; Positions=85; Note=Translated as Gln.; Evidence={ECO:0000305};
CC       Sequence=ACI46037.1; Type=Erroneous termination; Positions=85; Note=Translated as Gln.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/comt/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Catechol-O-methyl transferase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Catechol-O-methyl_transferase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M65212; AAA68927.1; -; mRNA.
DR   EMBL; M65213; AAA68928.1; -; mRNA.
DR   EMBL; M58525; AAA68929.1; -; mRNA.
DR   EMBL; Z26491; CAA81263.1; -; Genomic_DNA.
DR   EMBL; FJ224345; ACI46037.1; ALT_TERM; mRNA.
DR   EMBL; AK290440; BAF83129.1; -; mRNA.
DR   EMBL; CR456422; CAG30308.1; -; mRNA.
DR   EMBL; CR456997; CAG33278.1; -; mRNA.
DR   EMBL; AY341246; AAP88929.1; -; Genomic_DNA.
DR   EMBL; AC000080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC000090; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005663; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471176; EAX03010.1; -; Genomic_DNA.
DR   EMBL; BC000419; AAH00419.2; ALT_TERM; mRNA.
DR   EMBL; BC005867; AAH05867.1; ALT_TERM; mRNA.
DR   EMBL; BC011935; AAH11935.1; -; mRNA.
DR   EMBL; BC100018; AAI00019.1; -; mRNA.
DR   CCDS; CCDS13770.1; -. [P21964-1]
DR   CCDS; CCDS46663.1; -. [P21964-2]
DR   PIR; I37256; A38459.
DR   RefSeq; NP_000745.1; NM_000754.3. [P21964-1]
DR   RefSeq; NP_001128633.1; NM_001135161.1. [P21964-1]
DR   RefSeq; NP_001128634.1; NM_001135162.1. [P21964-1]
DR   RefSeq; NP_009294.1; NM_007310.2. [P21964-2]
DR   RefSeq; XP_016884083.1; XM_017028594.1. [P21964-1]
DR   RefSeq; XP_016884084.1; XM_017028595.1. [P21964-1]
DR   UniGene; Hs.370408; -.
DR   UniGene; Hs.693979; -.
DR   UniGene; Hs.713616; -.
DR   UniGene; Hs.738526; -.
DR   PDB; 3A7E; X-ray; 2.80 A; A=51-264.
DR   PDB; 3BWM; X-ray; 1.98 A; A=52-265.
DR   PDB; 3BWY; X-ray; 1.30 A; A=52-265.
DR   PDB; 4PYI; X-ray; 1.35 A; A=51-271.
DR   PDB; 4PYJ; X-ray; 1.90 A; A=51-271.
DR   PDB; 4PYK; X-ray; 2.22 A; A=51-271.
DR   PDB; 4XUC; X-ray; 1.80 A; A=48-265.
DR   PDB; 4XUD; X-ray; 2.40 A; A=48-265.
DR   PDB; 4XUE; X-ray; 2.30 A; A/B=52-265.
DR   PDB; 5LSA; X-ray; 1.50 A; A=51-271.
DR   PDBsum; 3A7E; -.
DR   PDBsum; 3BWM; -.
DR   PDBsum; 3BWY; -.
DR   PDBsum; 4PYI; -.
DR   PDBsum; 4PYJ; -.
DR   PDBsum; 4PYK; -.
DR   PDBsum; 4XUC; -.
DR   PDBsum; 4XUD; -.
DR   PDBsum; 4XUE; -.
DR   PDBsum; 5LSA; -.
DR   ProteinModelPortal; P21964; -.
DR   SMR; P21964; -.
DR   BioGrid; 107707; 21.
DR   IntAct; P21964; 27.
DR   MINT; MINT-4529967; -.
DR   STRING; 9606.ENSP00000354511; -.
DR   BindingDB; P21964; -.
DR   ChEMBL; CHEMBL2023; -.
DR   DrugBank; DB02342; 2-Methoxyestradiol.
DR   DrugBank; DB03336; BIA.
DR   DrugBank; DB00286; Conjugated Equine Estrogens.
DR   DrugBank; DB00255; Diethylstilbestrol.
DR   DrugBank; DB00841; Dobutamine.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB00494; Entacapone.
DR   DrugBank; DB00968; Methyldopa.
DR   DrugBank; DB01141; Micafungin.
DR   DrugBank; DB04820; Nialamide.
DR   DrugBank; DB00118; S-Adenosylmethionine.
DR   DrugBank; DB01420; Testosterone Propionate.
DR   DrugBank; DB00323; Tolcapone.
DR   GuidetoPHARMACOLOGY; 2472; -.
DR   iPTMnet; P21964; -.
DR   PhosphoSitePlus; P21964; -.
DR   SwissPalm; P21964; -.
DR   BioMuta; COMT; -.
DR   DMDM; 116907; -.
DR   REPRODUCTION-2DPAGE; IPI00375513; -.
DR   EPD; P21964; -.
DR   MaxQB; P21964; -.
DR   PaxDb; P21964; -.
DR   PeptideAtlas; P21964; -.
DR   PRIDE; P21964; -.
DR   TopDownProteomics; P21964-1; -. [P21964-1]
DR   TopDownProteomics; P21964-2; -. [P21964-2]
DR   DNASU; 1312; -.
DR   Ensembl; ENST00000361682; ENSP00000354511; ENSG00000093010. [P21964-1]
DR   Ensembl; ENST00000403710; ENSP00000385917; ENSG00000093010. [P21964-1]
DR   Ensembl; ENST00000406520; ENSP00000385150; ENSG00000093010. [P21964-1]
DR   Ensembl; ENST00000407537; ENSP00000384654; ENSG00000093010. [P21964-1]
DR   Ensembl; ENST00000449653; ENSP00000416778; ENSG00000093010. [P21964-2]
DR   GeneID; 1312; -.
DR   KEGG; hsa:1312; -.
DR   UCSC; uc002zqu.4; human. [P21964-1]
DR   CTD; 1312; -.
DR   DisGeNET; 1312; -.
DR   GeneCards; COMT; -.
DR   GeneCards; MIR4761; -.
DR   HGNC; HGNC:2228; COMT.
DR   HPA; CAB011233; -.
DR   HPA; HPA001169; -.
DR   MalaCards; COMT; -.
DR   MIM; 103780; phenotype.
DR   MIM; 116790; gene+phenotype.
DR   neXtProt; NX_P21964; -.
DR   OpenTargets; ENSG00000093010; -.
DR   Orphanet; 567; 22q11.2 deletion syndrome.
DR   Orphanet; 240863; Cisplatin toxicity.
DR   Orphanet; 3140; Schizophrenia.
DR   PharmGKB; PA117; -.
DR   eggNOG; KOG1663; Eukaryota.
DR   eggNOG; COG4122; LUCA.
DR   GeneTree; ENSGT00390000011316; -.
DR   HOGENOM; HOG000046392; -.
DR   HOVERGEN; HBG005376; -.
DR   InParanoid; P21964; -.
DR   KO; K00545; -.
DR   OMA; GDEKGCI; -.
DR   OrthoDB; EOG091G0GQK; -.
DR   PhylomeDB; P21964; -.
DR   TreeFam; TF329140; -.
DR   BioCyc; MetaCyc:HS01791-MONOMER; -.
DR   BRENDA; 2.1.1.6; 2681.
DR   Reactome; R-HSA-156581; Methylation.
DR   Reactome; R-HSA-379397; Enzymatic degradation of dopamine by COMT.
DR   Reactome; R-HSA-379398; Enzymatic degradation of Dopamine by monoamine oxidase.
DR   SIGNOR; P21964; -.
DR   ChiTaRS; COMT; human.
DR   EvolutionaryTrace; P21964; -.
DR   GeneWiki; Catechol-O-methyl_transferase; -.
DR   GenomeRNAi; 1312; -.
DR   PRO; PR:P21964; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000093010; -.
DR   CleanEx; HS_COMT; -.
DR   ExpressionAtlas; P21964; baseline and differential.
DR   Genevisible; P21964; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0016206; F:catechol O-methyltransferase activity; TAS:Reactome.
DR   GO; GO:0102084; F:L-dopa O-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0008168; F:methyltransferase activity; TAS:Reactome.
DR   GO; GO:0008171; F:O-methyltransferase activity; TAS:ProtInc.
DR   GO; GO:0016036; P:cellular response to phosphate starvation; IEA:Ensembl.
DR   GO; GO:0032502; P:developmental process; IEA:Ensembl.
DR   GO; GO:0042420; P:dopamine catabolic process; IEA:Ensembl.
DR   GO; GO:0008210; P:estrogen metabolic process; IEA:Ensembl.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0032259; P:methylation; TAS:Reactome.
DR   GO; GO:0048609; P:multicellular organismal reproductive process; IEA:Ensembl.
DR   GO; GO:0045963; P:negative regulation of dopamine metabolic process; IEA:Ensembl.
DR   GO; GO:0035814; P:negative regulation of renal sodium excretion; IEA:Ensembl.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0042135; P:neurotransmitter catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0050668; P:positive regulation of homocysteine metabolic process; IEA:Ensembl.
DR   GO; GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0048265; P:response to pain; IEA:Ensembl.
DR   GO; GO:0007614; P:short-term memory; IEA:Ensembl.
DR   InterPro; IPR017128; Catechol_O-MeTrfase_euk.
DR   InterPro; IPR002935; O-MeTrfase_3.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   Pfam; PF01596; Methyltransf_3; 1.
DR   PIRSF; PIRSF037177; Catechol_O-mtfrase_euk; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   PROSITE; PS51682; SAM_OMT_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Catecholamine metabolism;
KW   Cell membrane; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Magnesium; Membrane; Metal-binding;
KW   Methyltransferase; Neurotransmitter degradation; Phosphoprotein;
KW   Polymorphism; Reference proteome; S-adenosyl-L-methionine;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    271       Catechol O-methyltransferase.
FT                                /FTId=PRO_0000020971.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     26       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     27    271       Extracellular. {ECO:0000255}.
FT   REGION      167    170       S-adenosyl-L-methionine binding.
FT   METAL       191    191       Magnesium. {ECO:0000269|PubMed:18486144}.
FT   METAL       219    219       Magnesium. {ECO:0000269|PubMed:18486144}.
FT   METAL       220    220       Magnesium. {ECO:0000269|PubMed:18486144}.
FT   BINDING      92     92       S-adenosyl-L-methionine; via amide
FT                                nitrogen. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01019,
FT                                ECO:0000269|PubMed:18486144}.
FT   BINDING     114    114       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01019}.
FT   BINDING     122    122       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01019,
FT                                ECO:0000269|PubMed:18486144}.
FT   BINDING     140    140       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01019,
FT                                ECO:0000269|PubMed:18486144}.
FT   BINDING     141    141       S-adenosyl-L-methionine; via amide
FT                                nitrogen. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01019}.
FT   BINDING     169    169       S-adenosyl-L-methionine; via amide
FT                                nitrogen. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01019}.
FT   BINDING     191    191       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01019,
FT                                ECO:0000269|PubMed:18486144}.
FT   BINDING     194    194       Substrate.
FT   BINDING     220    220       Substrate.
FT   BINDING     249    249       Substrate.
FT   MOD_RES     267    267       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P22734}.
FT   VAR_SEQ       1     50       Missing (in isoform Soluble).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018778.
FT   VARIANT      34     34       C -> S (in dbSNP:rs6270).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:1847521}.
FT                                /FTId=VAR_013925.
FT   VARIANT      72     72       A -> S (correlated with reduced enzyme
FT                                activity; could be a risk allele for
FT                                schizophrenia; dbSNP:rs6267).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:15645182,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_013926.
FT   VARIANT     102    102       A -> T (in dbSNP:rs5031015).
FT                                /FTId=VAR_020274.
FT   VARIANT     146    146       A -> V (in dbSNP:rs4986871).
FT                                /FTId=VAR_020275.
FT   VARIANT     158    158       V -> M (in allele COMT*2; associated with
FT                                low enzyme activity and thermolability;
FT                                may increase the tendency to develop high
FT                                blood pressure and abdominal obesity;
FT                                dbSNP:rs4680).
FT                                {ECO:0000269|PubMed:15461802,
FT                                ECO:0000269|PubMed:18442637,
FT                                ECO:0000269|PubMed:18474266,
FT                                ECO:0000269|PubMed:8807664,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_005139.
FT   CONFLICT    245    245       Q -> N (in Ref. 13; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        55     66       {ECO:0000244|PDB:3BWY}.
FT   HELIX        72     85       {ECO:0000244|PDB:3BWY}.
FT   HELIX        93    107       {ECO:0000244|PDB:3BWY}.
FT   STRAND      110    115       {ECO:0000244|PDB:3BWY}.
FT   STRAND      118    120       {ECO:0000244|PDB:4PYJ}.
FT   HELIX       121    127       {ECO:0000244|PDB:3BWY}.
FT   STRAND      135    141       {ECO:0000244|PDB:3BWY}.
FT   HELIX       143    155       {ECO:0000244|PDB:3BWY}.
FT   HELIX       159    161       {ECO:0000244|PDB:3BWY}.
FT   STRAND      162    167       {ECO:0000244|PDB:3BWY}.
FT   HELIX       169    172       {ECO:0000244|PDB:3BWY}.
FT   HELIX       173    175       {ECO:0000244|PDB:3BWY}.
FT   HELIX       176    180       {ECO:0000244|PDB:3BWY}.
FT   STRAND      185    190       {ECO:0000244|PDB:3BWY}.
FT   HELIX       194    196       {ECO:0000244|PDB:3BWY}.
FT   HELIX       197    206       {ECO:0000244|PDB:3BWY}.
FT   STRAND      210    219       {ECO:0000244|PDB:3BWY}.
FT   HELIX       221    225       {ECO:0000244|PDB:3BWY}.
FT   HELIX       227    235       {ECO:0000244|PDB:3BWY}.
FT   STRAND      239    247       {ECO:0000244|PDB:3BWY}.
FT   STRAND      251    262       {ECO:0000244|PDB:3BWY}.
SQ   SEQUENCE   271 AA;  30037 MW;  D2547A1C399AC758 CRC64;
     MPEAPPLLLA AVLLGLVLLV VLLLLLRHWG WGLCLIGWNE FILQPIHNLL MGDTKEQRIL
     NHVLQHAEPG NAQSVLEAID TYCEQKEWAM NVGDKKGKIV DAVIQEHQPS VLLELGAYCG
     YSAVRMARLL SPGARLITIE INPDCAAITQ RMVDFAGVKD KVTLVVGASQ DIIPQLKKKY
     DVDTLDMVFL DHWKDRYLPD TLLLEECGLL RKGTVLLADN VICPGAPDFL AHVRGSSCFE
     CTHYQSFLEY REVVDGLEKA IYKGPGSEAG P
//
